RECRUITING

Universal Genetic Testing for Cancer Risk Reduction

Description

The purpose of this research study is to see if offering genetic testing for cancer-related genes is feasible and acceptable for patients presenting for gynecology clinic visits, instead of needing to see specialized providers or needing to meet specific criteria. The primary aim to assess the proportion of patients who undergo genetic testing, and the proportion of patients with pathogenic variants.

Conditions

Study Overview

Study Details

Study overview

The purpose of this research study is to see if offering genetic testing for cancer-related genes is feasible and acceptable for patients presenting for gynecology clinic visits, instead of needing to see specialized providers or needing to meet specific criteria. The primary aim to assess the proportion of patients who undergo genetic testing, and the proportion of patients with pathogenic variants.

Universal Genetic Testing for Cancer Risk Reduction

Universal Genetic Testing for Cancer Risk Reduction

Condition
Genetic Testing
Intervention / Treatment

-

Contacts and Locations

New York

NYU Langone Health, New York, New York, United States, 10016

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Female patients between ages of 25-39 years at the time of visit
  • 2. Receive gynecologic care at an affiliated NYU Langone Health (NYULH) site listed in this protocol.
  • 1. Personal history of ovarian, fallopian tube, primary peritoneal, or uterine cancers
  • 2. Previously undergone germline testing for ovarian cancer risk variants (prior commercial saliva-based kits, such as 23andMe, are acceptable)
  • 3. History of bilateral salpingo-oophorectomy
  • 4. Visit related to pregnancy or immediately postpartum (within 2 weeks)

Ages Eligible for Study

25 Years to 39 Years

Sexes Eligible for Study

FEMALE

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

NYU Langone Health,

Bhavana Pothuri, MD, MS, PRINCIPAL_INVESTIGATOR, NYU Langone Health

Study Record Dates

2027-12-31